Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioharvest Sciences (BHST) Gains from Sales and Divestitures (2024)

Historic Gains from Sales and Divestitures for Bioharvest Sciences (BHST) over the last 1 years, with Q4 2024 value amounting to $8.6 million.

  • Bioharvest Sciences' Gains from Sales and Divestitures changed N/A to $8.6 million in Q4 2024 from the same period last year, while for Dec 2024 it was $8.6 million, marking a year-over-year change of. This contributed to the annual value of $8.6 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that Bioharvest Sciences reported Gains from Sales and Divestitures of $8.6 million as of Q4 2024.
  • Bioharvest Sciences' Gains from Sales and Divestitures' 5-year high stood at $8.6 million during Q4 2024, with a 5-year trough of $8.6 million in Q4 2024.